Protein-liposome conjugates with defined size distributions

Area of Science:

• Biotechnology
• Materials Science
• Nanotechnology

Background:

• Protein conjugation to liposomes is a key technique in drug delivery and diagnostics.
• Existing conjugation methods often lead to liposome aggregation, affecting stability and circulation time.
• Developing stable, homogeneously sized protein-liposome conjugates is crucial for effective in vivo applications.

Purpose of the Study:

• To develop a method for generating stable, homogeneously sized protein-conjugated liposomes.
• To investigate the effect of extrusion on aggregated liposome-protein conjugates.
• To evaluate the in vivo performance of extruded versus aggregated protein-liposome conjugates.

Main Methods:

• Two coupling protocols were used for protein conjugation to liposomes, resulting in vesicle aggregation.
• Highly aggregated liposome-protein conjugates were extruded through filters with defined pore sizes.
• Liposome size, protein binding, and in vivo circulation times were analyzed.

Main Results:

• Extrusion effectively produced stable, homogeneously sized protein-liposome conjugates without protein loss.
• Extruded streptavidin-liposome conjugates showed significantly enhanced blood circulation lifetimes compared to aggregated ones.
• In vivo studies confirmed the stability of extruded streptavidin-liposome conjugates through biotin binding assays.

Conclusions:

• Extrusion is a convenient and general method for preparing homogeneously sized protein-liposome conjugates.
• This method overcomes aggregation issues associated with protein-liposome coupling.
• The improved stability and circulation of extruded conjugates offer advantages for liposome-based therapies.